体外膜氧合治疗大面积肺栓塞:ELSO数据库分析
该研究为ELSO数据库回顾性观察研究,纳入821例因肺栓塞接受ECMO的成人患者,共833次ECMO运行。VA ECMO最常见(58.7%),其次为ECPR(27.4%)和VV ECMO(10.2%),ECMO例数逐年增加主要由ECPR增加驱动。院内死亡率ECPR最高(156/229,68.1%),VA ECMO为209/498(42.7%),VV ECMO为24/85(28.2%),P<0.001。校正后年龄增加(OR 1.02)、较低pH(OR 0.18)、较低舒张压(OR 0.99)和ECPR模式(OR 3.67)与院内死亡独立相关,作者认为应避免延迟启动ECMO。
要点
- 833次ECMO运行中院内死亡率ECPR 68.1%(156/229)、VA ECMO 42.7%(209/498)、VV ECMO 28.2%(24/85),P<0.001。
- 校正后ECPR模式与院内死亡独立相关(OR 3.67,95%CI 1.46-9.230)。
- 校正后较低pH与院内死亡独立相关(OR 0.18,95%CI 0.03-0.44),作者提示应避免延迟启动ECMO。
- 450例(54.7%)在ECMO启动前发生心脏骤停,VA ECMO为最常用模式(489例,58.7%)。
适用人群与场景
- ELSO数据库中因大面积肺栓塞接受ECMO治疗的821例患者,共833次ECMO运行。
- 平均年龄49(±15)岁,408例(50.1%)为女性,450例(54.7%)在ECMO启动前发生心脏骤停。
研究设计与关键结果
- 研究类型:ELSO数据库回顾性观察研究,共821例患者、833次ECMO运行。
- ECMO模式分布:VA ECMO 489例(58.7%),ECPR 229例(27.4%),VV ECMO 85例(10.2%)。
- 院内死亡率:ECPR 156/229(68.1%),VA ECMO 209/498(42.7%),VV ECMO 24/85(28.2%),P<0.001。
- 校正单因素和ECMO启动时临床显著变量后,与院内死亡独立相关的因素:年龄增加(OR 1.02,95%CI 1.00-1.03)、较低pH(OR 0.18,95%CI 0.03-0.44)、较低舒张压(OR 0.99,95%CI 0.97-1.00)、ECPR模式(OR 3.67,95%CI 1.46-9.230)。
- 研究期间每年ECMO运行例数增加,主要由ECPR增加驱动。
证据类型、等级与局限
- 证据类型:回顾性观察研究(ELSO数据库分析)。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为,使用ECPR和启动时代谢状态恶化与较高的院内死亡率相关,提示应避免延迟启动ECMO。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
AIM: Extracorporeal membrane oxygenation (ECMO) may be beneficial in treatment of massive pulmonary embolus (PE), however the current evidence to guide its use is limited. We aimed to compare the incidence, characteristics, treatments, and outcomes of patients with massive PE by mode of ECMO from a large international registry.
METHODS: Retrospective observational study of the Extracorporeal Life Support Organization (ELSO) database.
RESULTS: A total of 821 patients underwent 833 ECMO episodes for PE. Mean age was 49 (±15) years, 408 (50.1%) were female, and 450 (54.7%) had a cardiac arrest prior to ECMO initiation. Venoarterial (VA) ECMO was the most common mode in 489 (58.7%), followed by extracorporeal cardiopulmonary resuscitation (ECPR) in 229 (27.4%) and venovenous (VV) ECMO in 85 (10.2%). The number of episodes per year increased over the study period, predominantly driven by an increase in ECPR. In-hospital mortality was the highest for ECPR 156/229 (68.1%), followed by VA ECMO 209/498 (42.7%) and VV ECMO 24/85 (28.2%) P < 0.001. After controlling for univariate and clinically significant variables at the time of ECMO initiation, increasing age (OR 1.02 (1.00-1.03), lower pH (OR 0.18 (0.03-0.44), lower diastolic blood pressure (OR 0.99 (0.97-1.00) and ECPR mode (OR 3.67 (1.46-9.230) were independently associated with in-hospital mortality.
CONCLUSION: ECMO use for massive PE is increasing globally, and overall mortality rates compare favorably with other indications of ECMO. The use of ECPR and worsening metabolic status at initiation were associated with higher in-hospital mortality, suggesting delays in initiating ECMO should be avoided.
参考来源
- Rivers J, Pilcher D, Kim J, et al. Extracorporeal membrane oxygenation for the treatment of massive pulmonary embolism. An analysis of the ELSO database. Resuscitation. 2023. PMID: 37625576. doi:10.1016/j.resuscitation.2023.109940
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。